The short answer
Ephedra products containing ephedrine alkaloids can cause serious stimulant-related harm and may add to amantadine-related symptoms. Do not use these products without medical review; no safe combination dose has been established.
What this answer covers
Ephedra sinica preparations containing ephedrine alkaloids; not every alkaloid-free product.
- Supplement or preparation
- Ephedra sinica
- Medication ingredient
- amantadine
What the medicine warning covers
Amantadine labeling calls for careful observation with CNS stimulants. That general warning must be matched to the actual constituents of a botanical product; it does not identify every plant preparation as having the same effect.
What the botanical evidence shows
Federal guidance describes serious cardiovascular and neurologic risks from ephedrine-alkaloid supplements, including at relatively low doses or short durations. The US prohibition concerns those alkaloid-containing dietary supplements.
The exact combination remains unmeasured
No inspected human study quantified this botanical’s added risk with amantadine. Food, concentrated extracts and mixed stimulant products cannot be assigned a common effect size. Intrinsic botanical toxicity is not itself a measured interaction.
Check the complete product
Show the clinician the ingredient list, including caffeine or other stimulants. Seek urgent help for chest pain, fainting, severe agitation or seizures. Do not rely on spacing doses to make a stimulant product safe.
Evidence and practical considerations
Side effects & toxicity
Conditional overlapping stimulant concern for confirmed ephedrine-alkaloid products based on exact amantadine labeling and federal botanical safety evidence; no pair incidence or safe interval established.
- Exact scope
- Ephedra sinica preparations containing ephedrine alkaloids; not every alkaloid-free product. with Oral amantadine hydrochloride immediate-release capsules; GOCOVRI extended-release considered separately.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed amantadine
May cause insomnia, agitation or somnolence; careful observation with CNS stimulants and other CNS-active medicines. Renal elimination and seizure-history precautions.
How this applies: Exact amantadine RxCUI 620 IN, with stated salt/formulation/route bridge.
No exact supplement-combination incidence or validated protective spacing; salt, route and release form limits apply.
Source 2: Federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering the named supplement.
Ephedrine-alkaloid dietary supplements carry serious cardiovascular risks and are banned in the U.S.; cardiovascular disease is a concern.
How this applies: Interpreted for amantadine only within the stated exact preparation and endpoint limits.
Ephedrine-alkaloid products have intrinsic stimulant/cardiovascular risks; no measured amantadine-specific increment or safe threshold. Alkaloid-free preparations not assumed equivalent.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Prepared exact amantadine article with formulation-specific evidence and uncertainty. |
Article revision: 4858d507aa130759
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.